Recently, Smoore International Holdings Limited (hereinafter referred to as "Smoore", stock code: 6969) released its financial update for the period ending on September 30, 2024. According to the financial report, in the third quarter of 2024, Smoore's revenue reached 32.861 billion RMB, representing a 16.5% growth compared to the previous quarter and a 14.1% growth compared to the same period last year. The company's net profit after tax was 3.789 billion RMB, an increase of 10.2% compared to the previous quarter but a decrease of 22.5% year-on-year.
In the third quarter of 2024, Smoore's revenue reached 3.286 billion yuan, an increase of 16.5% compared to the previous quarter and 14.1% compared to the same period last year. This growth is primarily attributed to an increase in revenue from proprietary brand products and closed-loop products in the enterprise customer business. As of September 30, 2024, the company's total revenue was 8.3234 billion yuan, a year-on-year increase of 4.0%.
In the third quarter of 2024, Smoore Company's net profit after tax was 3.789 billion RMB, showing a quarter-on-quarter increase of 10.2% from 3.437 billion RMB in the second quarter. However, it decreased by 22.5% compared to 4.887 billion RMB in the same period last year. In the first nine months of 2024, the total net profit after tax was 10.621 billion RMB, a year-on-year decrease of 11.9% from 12.06 billion RMB in the same period in 2023. This decrease is mainly attributed to a significant increase in the provision for income tax expenses compared to the same period last year.
Smoore stated that the company will continue to increase investment in product development for HNB products and vaporized medical products projects.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
